Hydromer, Inc. (OTC: HYDI), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices, reported preliminary unaudited financial results for the quarter ended September 30, 2025. The company generated revenue of $0.91 million during the third quarter, representing an 11% increase compared to $0.81 million in the same period of 2024. This growth reflects the company's continued market position in surface modification technologies.
The medical device coating specialist reported a net income of $53,000 in the third quarter, marking a return to profitability after previous quarters. Michael Torti, CEO of Hydromer, stated that the company maintains a high level of customer loyalty and is beginning to see growth from new customers entering its production coating line-up. The company's focus on operational efficiency and customer partnerships appears to be yielding positive financial results.
Hydromer continues to invest in infrastructure and equipment needs while maintaining a strong emphasis on new product development. The company's commitment to building a scalable, innovation-driven platform positions it for potential future growth in the medical device coating market. However, management noted concerns about the artificially low valuation of HYDI stock and associated difficulties in trading, prompting plans to return the stock to the OTCID Basic Market to address these challenges.
The preliminary results are based on the most current information available to management but remain subject to completion of the company's 2025 year-end financial reporting processes, reviews, audit, and potential adjustments. Investors should view these numbers as preliminary until final audited results are released. The original release can be viewed on www.newmediawire.com for additional context.
As an ISO 9001:2015 certified company with facilities compliant to Good Manufacturing Practice and ISO 13485 standards, Hydromer has built its reputation over 44 years in the industry. The company's ability to return to profitability while maintaining revenue growth suggests potential stability in its business model, though the planned stock market transition and ongoing investments in technology development will be critical factors to monitor in coming quarters.
